However, there were no significant microscopically identifiable differences between the degree of inflammation or types and configuration of adenomas between AOM/DSS-treated mice ± M(IL4) at day 33 or day 54 groups (Figure 3D). The gene discussed is IL4; the disease is infectious otitis media.